RPS19 induces the production of immunosuppressive cytokines and promotes tumor growth which can be impaired by the blockage of RPS19 [64] while the knockdown of RPL39 in triple-negative breast cancer (TNBC) xenografts reduces significantly primary tumor growth, as well as metastasis [65]. Here, RPS19 is linked to neoplasm.